Pfizer has a second FDA approval for a migraine therapy stemming from its ... to be accompanied by nausea – which can make taking tablets difficult. Sales of Nurtec ODT (rimegepant) – approved ...

Zavegepant hydrochloride is under clinical development by Pfizer and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Pfizer's $1.2 billion licensing deal with Biohaven for rights to oral migraine drug rimegepant is approaching a payoff after the European Commission approved the drug.

Pfizer will use social media ads to find patients and funnel them to the new portal. The entry point will be whatever health ...

Now, in final draft guidance, it says the Pfizer-made medicine (also called Vydura) is a cost-effective option for treatment of migraine attacks once they have started. The drug will benefit those ...